The field of partial reprogramming is transitioning from successful mouse studies to its first human clinical trials. At the heart of this experiment lies the discovery of Yamanaka ...
Life Biosciences, a Boston longevity biotech co-founded by Harvard genetics professor David Sinclair, has locked down an $80 ...
Systemic candidiasis is an opportunistic fungal infection that has been difficult to treat effectively. Research published in ...
HexemBio has launched with a seed round led by Draper Associates to advance a blood stem cell rejuvenation therapy backed by Robert Langer.
HexemBio emerges with a breakthrough blood stem cell rejuvenation technology led by Draper Associates and an advisory ...
A first-of-its-kind study led by the Medical University of South Carolina raises questions about the value of fish oil ...
Interesting Engineering on MSN
New AI system lets robots understand and act on human commands in real time
Robots can now turn plain language into real-world actions using a new framework that ...
The FX Aegis series starts at $2,490, with an ecosystem skill package for the second development version starting at $1,000. FF EAI robotics achieved positive product gross margins in Q1 2026, and the ...
Dr. Lun Yu explains how advanced molecular design can enable peptides to target the biological roots of skin ageing, turning longevity science into actionable innovation ...
Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) ("Faraday Future", "FF" or the "Company"), a California-based global Embodied AI (EAI) ecosystem company, announced today that its Global ...
Scientists at the Salk Institute for Biological Studies and Sanford Burnham Prebys explore genetic factors in separate papers ...
In an interview with Torbjörn Ogéus, Stockholms led- & smärtklinik (SLS), Open Access Government explores how the landscape of regenerative medicine is shifting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results